Q2 2020 13F Holders as of 30 Jun 2020
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
6,908,018
-
Share change
-
-2,344,697
-
Total reported value
-
$5,913,000
-
Price per share
-
$0.86
-
Number of holders
-
27
-
Value change
-
-$1,886,462
-
Number of buys
-
13
-
Number of sells
-
7
Institutional Holders of ZOSANO PHARMA CORP - COM NEW (ZSAN) as of Q2 2020
As of 30 Jun 2020,
ZOSANO PHARMA CORP - COM NEW (ZSAN) was held by
27 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
6,908,018 shares.
The largest 10 holders included
Aisling Capital Management LP, VANGUARD GROUP INC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Alyeska Investment Group, L.P., NORTHERN TRUST CORP, Telemetry Investments, L.L.C., UBS Group AG, and Qube Research & Technologies Ltd.
This page lists
27
institutional shareholders reporting positions in this security
for the Q2 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.